» Articles » PMID: 27507964

Gut Microbiota Profiling: Metabolomics Based Approach to Unravel Compounds Affecting Human Health

Overview
Journal Front Microbiol
Specialty Microbiology
Date 2016 Aug 11
PMID 27507964
Citations 176
Authors
Affiliations
Soon will be listed here.
Abstract

The gut microbiota is composed of a huge number of different bacteria, that produce a large amount of compounds playing a key role in microbe selection and in the construction of a metabolic signaling network. The microbial activities are affected by environmental stimuli leading to the generation of a wide number of compounds, that influence the host metabolome and human health. Indeed, metabolite profiles related to the gut microbiota can offer deep insights on the impact of lifestyle and dietary factors on chronic and acute diseases. Metagenomics, metaproteomics and metabolomics are some of the meta-omics approaches to study the modulation of the gut microbiota. Metabolomic research applied to biofluids allows to: define the metabolic profile; identify and quantify classes and compounds of interest; characterize small molecules produced by intestinal microbes; and define the biochemical pathways of metabolites. Mass spectrometry and nuclear magnetic resonance spectroscopy are the principal technologies applied to metabolomics in terms of coverage, sensitivity and quantification. Moreover, the use of biostatistics and mathematical approaches coupled with metabolomics play a key role in the extraction of biologically meaningful information from wide datasets. Metabolomic studies in gut microbiota-related research have increased, focusing on the generation of novel biomarkers, which could lead to the development of mechanistic hypotheses potentially applicable to the development of nutritional and personalized therapies.

Citing Articles

The Role of the Gut Microbiota in Health, Diet, and Disease with a Focus on Obesity.

Ma Z, Lee Y Foods. 2025; 14(3).

PMID: 39942085 PMC: 11817362. DOI: 10.3390/foods14030492.


Utilizing Lactic Acid Bacteria to Improve Hyperlipidemia: A Comprehensive Analysis from Gut Microbiota to Metabolic Pathways.

Ma C, Xu C, Zheng M, Zhang S, Liu Q, Lyu J Foods. 2025; 13(24.

PMID: 39767000 PMC: 11675396. DOI: 10.3390/foods13244058.


Advancements in precision medicine: multi-omics approach for tailored metformin treatment in type 2 diabetes.

Anwardeen N, Naja K, Elrayess M Front Pharmacol. 2024; 15:1506767.

PMID: 39669200 PMC: 11634602. DOI: 10.3389/fphar.2024.1506767.


Roles of the gut microbiota in human neurodevelopment and adult brain disorders.

Mallick R, Basak S, Das R, Banerjee A, Paul S, Pathak S Front Neurosci. 2024; 18:1446700.

PMID: 39659882 PMC: 11628544. DOI: 10.3389/fnins.2024.1446700.


Longitudinal analyses of infants' microbiome and metabolome reveal microbes and metabolites with seemingly coordinated dynamics.

Wu H, Guzior D, Martin C, Neugebauer K, Rzepka M, Lumeng J Commun Biol. 2024; 7(1):1506.

PMID: 39543263 PMC: 11564710. DOI: 10.1038/s42003-024-07015-6.


References
1.
Best C, Laposata M . Fatty acid ethyl esters: toxic non-oxidative metabolites of ethanol and markers of ethanol intake. Front Biosci. 2002; 8:e202-17. DOI: 10.2741/931. View

2.
Zheng X, Xie G, Zhao A, Zhao L, Yao C, Chiu N . The footprints of gut microbial-mammalian co-metabolism. J Proteome Res. 2011; 10(12):5512-22. DOI: 10.1021/pr2007945. View

3.
Scanlan P, Buckling A, Kong W, Wild Y, Lynch S, Harrison F . Gut dysbiosis in cystic fibrosis. J Cyst Fibros. 2012; 11(5):454-5. DOI: 10.1016/j.jcf.2012.03.007. View

4.
Milne S, Mathews T, Myers D, Ivanova P, Brown H . Sum of the parts: mass spectrometry-based metabolomics. Biochemistry. 2013; 52(22):3829-40. PMC: 3674197. DOI: 10.1021/bi400060e. View

5.
Carterson A, Morici L, Jackson D, Frisk A, Lizewski S, Jupiter R . The transcriptional regulator AlgR controls cyanide production in Pseudomonas aeruginosa. J Bacteriol. 2004; 186(20):6837-44. PMC: 522194. DOI: 10.1128/JB.186.20.6837-6844.2004. View